SALA DE PRENSA DE RENOWN

Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.”   The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. Acerca de Helix Helix es la compañía líder en genómica y vigilancia viral de la población cuyas operaciones se basan en el cuidado clínico, la investigación y el análisis de datos. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.

Leer más About Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

El sistema de salud sigue el anuncio del gobernador de reanudar las cirugías necesarias el 11 de mayo, pero permanece listo para un posible aumento de casos de COVID-19. Renown Health announced today that they will align with the Governor’s Office and the state Medical Advisory Team in adopting a phased-in approach to resume limited medical and surgical procedures under strict guidelines and lift temporary restrictions due to the COVID-19 virus. The decision follows yesterday’s release of Governor Sisolak’s “Nevada United: A Roadmap to Recovery,” a plan designed to move forward to safely restart Nevada under a “new normal.” Desde el lunes 4 de mayo, el sistema de salud implementará un enfoque por fases para realizar cirugías necesarias para pacientes que no estén en riesgo, las cuales comenzarán a realizarse el lunes, 11 de mayo de 2020. “We’re able to resume some surgical services due to the flattening of the COVID-19 surge curve and the low COVID-19 transmission rate within our community due to the implementation of strong social distancing practices,” said Tony Slonim, MD, D.Ph., President and CEO, Renown Health. He added, “Our primary concern will always be the health and safety of our patients, physicians, healthcare employees and community members. We continue to monitor the surge curve and our current situation. Until a vaccine or cure is found, Renown Health remains prepared at all times to handle a surge and continues to care for those across northern Nevada.” Los casos de procedimientos “electivos opcionales” se pospusieron temporalmente en los hospitales de Renown el 17 de marzo, con el fin de detener la propagación de la COVID-19 y preservar los recursos críticos. Christopher P. Demers, MD, FAANS, socio gerente en Sierra Neurosurgery Group y director médico de Neurocirugía en Renown, dijo: “Sé lo importante que son las cirugías para mejorar la calidad de vida de los pacientes. I am privileged to have the opportunity to perform surgeries that help people get back to doing the activities they love. We are guided by a simple and important principle: the patient always comes first.” “This is excellent news for so many patients who may have placed their surgeries and care plans on hold due to COVID-19,” said Christos Galanopoulos, MD, chair, department of surgery for Renown Medical Group, and a specialist in oncologic surgery. “Renown’s expert team is ready to deliver safe and effective care to all patients and has earned recognition as the region’s leader in patient safety, technology and specialized care,” said Galanopoulos. “We are proud of the incredibly detailed health and safety measures in place at Renown.” Health and safety protocols in place at Renown facilities include: Todas las personas que ingresan a centros de Renown, incluidos los miembros del equipo, deben someterse a un examen de detección de síntomas de COVID-19; los pacientes que tienen programados procedimientos electivos se realizarán una prueba de COVID-19 hasta 5 días antes de la fecha programada para el procedimiento. Patients will remain in isolation following the test, up to the time of surgery. Positive COVID-19 patients and symptomatic patients will not be scheduled for elective surgery. All individuals entering Renown sites are asked to don a cloth mask. Patients may bring their own mask or may opt to wear one supplied by Renown. All care team members wear surgical masks and protective eye wear, as well as other necessary personal protective equipment (PPE), at all times when caring for patients. Visitor restrictions are still in place. Se alienta que haya una persona de apoyo para pacientes quirúrgicos, madres que van a dar a luz; niños menores de 18 años; pacientes con confusión, estado mental alterado o retrasos en el desarrollo y pacientes que se encuentran en el final de su vida. Six-foot social distances have been established in public areas such as waiting rooms, elevators, cafeterias. Extra cleaning and disinfection is in place for all high-touch, public surface areas. Erik Olson, MHA, Chief Executive Officer of Renown Regional Medical Center adds, “Renown’s mission is to make a genuine difference in the health and well-being of the people and communities we serve. We deliver on this promise by collaborating with expert surgeons to offer general and specialized surgical interventions to alleviate disabilities and reduce the risk of death from traumatic injuries, cancers, cardiovascular disease and other conditions. Together we are dedicated to delivering safe, high-quality, compassionate, personalized health care.” Los pacientes que deseen programar una cirugía electiva o procedimiento ambulatorio primero deben comunicarse con el proveedor que solicita el procedimiento. -FINAL- Se invita a aquellos interesados en apoyar a los héroes de la atención médica de Renown a visitar www.renown.org/give para conocer más formas de ayudar. Para obtener información actualizada sobre el abordaje de Renown para mantener la seguridad de la comunidad, visite nuestro sitio web en www.renown.org/covid-19/.     About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. Visite renown.org para obtener más información.

Leer más About Renown reanuda las cirugías médicamente necesarias en un enfoque por fases